Differential Expression of COX-1 and COX-2 in the Gastrointestinal Tract of the Rat
暂无分享,去创建一个
[1] K. Westover,et al. Determination of expression of cyclooxygenase-1 and -2 isozymes in canine tissues and their differential sensitivity to nonsteroidal anti-inflammatory drugs. , 2004, American journal of veterinary research.
[2] L. Kopelovich,et al. Cyclooxygenases in the skin: pharmacological and toxicological implications. , 2003, Toxicology and applied pharmacology.
[3] R. Simpson,et al. NSAIDs: the Emperor’s new dogma? , 2003, Gut.
[4] R. Simpson,et al. COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice. , 2002, Gastroenterology.
[5] A. Tarnawski,et al. NSAID inhibition of RGM1 gastric monolayer wound re-epithelialization: comparison of selective Cox-2 versus non-selective Cox inhibitors. , 2002, Life sciences.
[6] K. Takeuchi,et al. Up‐regulation of COX‐2 by inhibition of COX‐1 in the rat: a key to NSAID‐induced gastric injury , 2002, Alimentary pharmacology & therapeutics.
[7] 二神 綾子. Wound healing involves induction of cyclooxygenase-2 expression in rat skin , 2002 .
[8] P. O’Brien,et al. Rat colorectal tumours treated with a range of non-steroidal anti-inflammatory drugs show altered cyclooxygenase-2 and cyclooxygenase-1 splice variant mRNA expression levels. , 2001, Carcinogenesis.
[9] H. Roy,et al. Distal bowel selectivity in the chemoprevention of experimental colon carcinogenesis by the non‐steroidal anti‐inflammatory drug nabumetone , 2001, International journal of cancer.
[10] S. Miyamoto,et al. Upregulation of iNOS by COX-2 in muscularis resident macrophage of rat intestine stimulated with LPS. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[11] R. Lorenz,et al. Spontaneous and Continuous Cyclooxygenase-2-Dependent Prostaglandin E2 Production by Stromal Cells in the Murine Small Intestine Lamina Propria: Directing the Tone of the Intestinal Immune Response1 , 2001, The Journal of Immunology.
[12] B. Thjódleifsson,et al. Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen , 2001, Gut.
[13] J. Wallace,et al. NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. , 2000, Gastroenterology.
[14] I. Bjarnason,et al. Comparison of the intestinal toxicity of celecoxib, a selective COX-2 inhibitor, and indomethacin in the experimental rat. , 2000, Scandinavian journal of gastroenterology.
[15] S. Yamashina,et al. Cyclo‐oxygenase‐2 enhances basic fibroblast growth factor‐induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants , 2000, British journal of pharmacology.
[16] P. O’Brien,et al. Cyclooxygenase-1 and an alternatively spliced mRNA in the rat stomach: effects of aging and ulcers. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[17] G Geisslinger,et al. Effects of selective and unselective cyclooxygenase inhibitors on prostanoid release from various rat organs. , 2000, The Journal of pharmacology and experimental therapeutics.
[18] A B West,et al. Myofibroblasts. II. Intestinal subepithelial myofibroblasts. , 1999, American journal of physiology. Cell physiology.
[19] C. Hawkey. COX-2 inhibitors , 1999, The Lancet.
[20] C. Bonifer,et al. © 1999 Cancer Research Campaign Article no. bjoc.1998.0224 Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice , 2022 .
[21] D. Powell. Intestinal subepithelial myofibroblasts , 1999 .
[22] J. Mazuski,et al. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis. , 1999, The Journal of surgical research.
[23] G. Crosthwaite,et al. Proton pump inhibitors for Barrett's oesophagus , 2000, Gut.
[24] K. Schrör,et al. Constitutive cyclooxygenase-2 expression in healthy human and rabbit gastric mucosa. , 1998, Molecular pharmacology.
[25] P. Netzer,et al. Effects of inhibition of prostaglandin endoperoxide synthase‐2 in chronic gastro‐intestinal ulcer models in rats , 1998, British journal of pharmacology.
[26] K. Seibert,et al. Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1. , 1997, The Journal of clinical investigation.
[27] Y. Watanabe,et al. Induction of Cyclooxygenase‐2 in the Brain by Cytokines , 1997, Annals of the New York Academy of Sciences.
[28] M. Kasuga,et al. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. , 1997, Gastroenterology.
[29] J. Wallace,et al. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. , 1996, The Journal of clinical investigation.
[30] J. Mitchell,et al. Cyclooxygenase-2: regulation and relevance in inflammation. , 1995, Biochemical pharmacology.
[31] Hyung-Suk Kim,et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration , 1995, Cell.
[32] A. Dhillon,et al. Intestinal site‐dependent susceptibility to chronic indomethacin in the rat: a morphological and biochemical study , 1995, Alimentary pharmacology & therapeutics.
[33] J. Otto,et al. Different Intracellular Locations for Prostaglandin Endoperoxide H Synthase-1 and −2 (*) , 1995, The Journal of Biological Chemistry.
[34] J. Otto,et al. The orientation of prostaglandin endoperoxide synthases-1 and -2 in the endoplasmic reticulum. , 1994, The Journal of biological chemistry.
[35] A. Levi,et al. Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. , 1987, Gastroenterology.
[36] R. Tompkins. Nonsteroidal anti-inflammatory drugs. , 2019, Minnesota medicine.